Skip to content

PFE

PFIZER INC

NYSE · Healthcare · Drug Manufacturers - General · US

$30.42
+1.38%
Ask drillr
  • Nov 4, 2026, 12:00 UTC

    United Therapeutics entered into an amendment with Arena Pharmaceuticals that eliminates all royalty obligations under their ralinepag license agreement in exchange for an upfront payment of $525 million.

  • Nov 3, 2026, 14:00 UTC

    PFIZER INC reported quarterly earnings of $0.87 per share, above the Zacks Consensus Estimate of $0.72 per share and equal to earnings a year earlier.

    Source:
  • Nov 3, 2026, 12:00 UTC

    PFIZER INC appointed Cecile Guegan as chief financial officer, and she stepped into the role in November 2026.

    Source:
  • Nov 3, 2026, 11:47 UTC

    PFIZER INC raised its 2026 adjusted earnings-per-share guidance to $2.95–$3.05 and revenue guidance to $62.0–$64.0 billion.

  • Nov 3, 2026, 11:45 UTC

    PFIZER INC reported third-quarter adjusted earnings per share of $0.87, above the $0.73 estimate.

  • Oct 28, 2026, 19:58 UTC

    Crews completed lifting the sagging floors at the former PFIZER INC headquarters, allowing the 1,600-unit office-to-apartment conversion to resume after a structural failure.

  • Oct 27, 2026, 17:25 UTC

    Pfizer released topline results from its Phase 3 MagnetisMM-32 study evaluating Elrexfio (elranatamab) as a monotherapy in patients with multiple myeloma.

  • Oct 26, 2026, 17:41 UTC

    The U.S. Food and Drug Administration expanded approval of Pfizer's TALZENNA in combination with XTANDI for men with HRR gene-mutated metastatic androgen pathway modulation-naïve or -sensitive prostate cancer.

  • Oct 25, 2026, 23:15 UTC

    Dutch plaintiffs’ civil case alleging COVID-19 injections caused harm and involved coordinated deception proceeded to a substantive hearing against Bill Gates, PFIZER INC CEO Albert Bourla, former Prime Minister Mark Rutte and others.

  • Oct 24, 2026, 15:18 UTC

    Pfizer announced Phase 2 study results showing that its investigational 25-valent pneumococcal conjugate vaccine candidate elicited immune responses against all 25 serotypes in infants, with safety and tolerability comparable to PREVNAR 20.

  • Oct 22, 2026, 17:45 UTC

    A federal appeals court dismissed Alex Berenson’s lawsuit against PFIZER INC executives over alleged pressure on X to censor him.

  • Oct 21, 2026, 23:59 UTC

    New York City’s Department of Buildings approved plans for permanent structural repairs to the PFIZER INC after review by department engineers and an independent engineering firm.

    Source:
  • Oct 21, 2026, 03:25 UTC

    JD Health International, Inc. and PFIZER INC entered into a strategic cooperation covering several disease areas, with a focus in the next phase on Xianweiying (enoglutide injection) and collaboration in weight management and metabolic health.

  • Oct 20, 2026, 22:46 UTC

    PFIZER INC shares closed at $30.11, up 2.28% from the previous trading day.

    Source:
  • Oct 19, 2026, 15:00 UTC

    Cboe Global Markets, Inc. launched extended pre-market and post-market trading sessions for selected U.S. single-stock and ETF options on its Cboe Global Markets, Inc..

  • Oct 16, 2026, 19:45 UTC

    MetroLoft’s redevelopment plan for the PFIZER INC now calls for crews to jack up sagging floors gradually, ultimately raising them about seven inches.

  • Oct 16, 2026, 14:00 UTC

    PFIZER INC confirmed that about 150 workers at its Portage, Michigan, manufacturing facility are losing their jobs because of lower production volumes amid weaker demand for some products.

  • Oct 14, 2026, 22:45 UTC

    PFIZER INC shares rose 2.96% to close at $29.21 while the broader market dipped.

    Source:
  • Oct 14, 2026, 10:45 UTC

    Pfizer announced that it will present data from more than 50 research abstracts, including 12 oral presentations, at PFIZER INC in Washington, D.C.

  • Oct 13, 2026, 11:00 UTC

    Enodia Therapeutics announced a research collaboration and license agreement with Pfizer to discover and develop Sec61 inhibitors using Enodia's proprietary platform.

  • Oct 12, 2026, 14:56 UTC

    PFIZER INC shares moved above their 50-day simple moving average.

    Source:
  • Oct 12, 2026, 07:56 UTC

    China's National Medical Products Administration approved PFIZER INC's enoglutide injection for an additional indication in adults with type 2 diabetes.

  • Oct 7, 2026, 16:57 UTC

    The U.S. Food and Drug Administration approved Pfizer's TUKYSA regimen with trastuzumab and pertuzumab for maintenance treatment of adults with unresectable locally advanced or metastatic HER2-positive breast cancer following induction treatment.

  • Oct 7, 2026, 14:21 UTC

    PFIZER INC plans to cut around 330 jobs at its plant in Sicily, according to labour unions.

  • Oct 5, 2026, 14:23 UTC

    Vaxcyte shares spiked 57% after its lead vaccine candidate showed trial results positioning it against Pfizer and Merck.

  • Oct 3, 2026, 14:45 UTC

    A Russian air strike on Friday, Oct. 2 set fire to a pharmaceutical storage warehouse belonging to Ukrainian drug distributor Venta near Kyiv, destroying inventories of medicines made by Bayer, Sanofi, Pfizer, Teva, Darnytsia and Farmak.

  • Oct 1, 2026, 22:46 UTC

    Pfizer (PFE) shares closed at $28.10, down 1.47% from the previous trading session.

    Source:
  • Sep 28, 2026, 10:45 UTC

    Pfizer announced it will present data from 45 research abstracts, including 11 oral presentations, at the European Society for Medical Oncology (ESMO) Congress in Madrid on October 23-27, 2026.

Page 1Next →